CB 399: Cancer Vaccines Spring 2012

Intellectual Unit:

Cancer Vaccines
Nanocourse Director: Glenn Bubley, David E Avigan and Simo Arredouani
Curriculum Fellow: Narveen Jandu


Tumor immunotherapy is an active area of research in the prevention and treatment of cancer.  Different types of cancer vaccines can be developed based on different tumor cell targets.  Whole cell of origin, cellular immunotherapy and both tumor and host cell environment must be taken into consideration. Several different types of Cancer Vaccines are currently under active investigation and some are in clinical trials. This nanocourse aims to cover the fundamentals of tumor immunotherapy, various models, and vaccine development – challenges and perspectives.  We will also explore both the technical and translational aspects of cancer vaccines.


Schedule:

First Session: Wednesday, February 29, 2012 2:00 - 5:00 pm   
Location: Harvard Medical School, Armenise Amphitheater
 
Second Session: Wednesday, March 7, 2012 2:00 - 5:00 pm
Location: TMEC Building, Room 447

 

Student Assignment:            

For all registered students taking this course for credit, please prepare 3 in-depth and detailed questions about one or more of the topics discussed in the lectures on Day 1.  These questions can be based on what you heard, should be thoughtful and aimed at stimulating an insightful discussion.  You may choose to prepare very direct questions, open-ended questions or questions around unresolved issues within the field and literature.  You should aim to address key issues and challenges in the field of Cancer Vaccine development.  You may also choose to prepare an experimental design on how you might approach answering a current research question in the field.  On Day 2 of this nanocourse, you will have the opportunity to discuss your questions with the lecturers and your peers.  Please come prepared.  This assignment must be submitted on Tuesday, March 6, 2012 in order to receive full credit. 

 

DROP DEADLINE: Wednesday, February 22, 2012 


AUDITORS (Post-Docs, Faculty, or Staff) DO NOT NEED TO SIGN UP TO ATTEND THE 1st SESSION.  PLEASE DO NOT ENROLL.